No Data
No Data
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)
Opaleye Management Inc. Reduces Stake in Protara Therapeutics Inc.
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating
TD Cowen analyst Stacy Ku maintains $Protara Therapeutics(TARA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 53.1% and a total average return of -3.7% over the
Express News | Protara Therapeutics Inc - Expects to Dose First Patient in Pivotal Pk Trial for IV Choline Chloride in Q1 2025
Express News | Protara Therapeutics Inc - Announces Results From Thrive-1
Express News | Protara Therapeutics Inc - Enrollment in Additional Cohorts Underway With Initial Results Expected in 1H'25